Eric S. Surrey

No ORCID on file · 89 papers in corpus · active 1989-2025

Study types

  • article 64
  • review 12
  • book-chapter 7
  • letter 2
  • other 2

Condition tags

  • endometriosis 83
  • chronic_pelvic_pain 13
  • dysmenorrhea 13
  • infertility 13
  • dyspareunia 8
  • interstitial_cystitis 1
  • die_deep_infiltrating 1
  • irritable_bowel_syndrome 1
book-chapter 2010
Controlled Ovarian Hyperstimulation in Endometriosis Patients
·doi:10.5005/jp/books/11032_26
review 2010
Gonadotropin-releasing hormone agonist and add-back therapy: what do the data show?
Current opinion in obstetrics & gynecology ·doi:10.1097/gco.0b013e32833b35a7

PURPOSE OF REVIEW: Endometriosis is a gynecologic disorder that can lead to debilitating chronic pelvic pain and infertility. Gonadotropin-releasing hormone agonists (GnRHa) have emerged as a primary medical therapy for patients with sympto…

article 2009
Does endometrial integrin expression in endometriosis patients predict enhanced in vitro fertilization cycle outcomes after prolonged GnRH agonist therapy?
Fertility and sterility ·doi:10.1016/j.fertnstert.2008.12.023
book-chapter 2008
Surgical Preparation of the Patient for In Vitro Fertilization
·doi:10.1017/cbo9780511547287.042

This chapter reviews the evidence surrounding the effect of reproductive surgery for tubal abnormalities, endometriosis, and uterine fibroids on in vitro fertilization (IVF) cycle outcome. Salpingectomy and proximal tubal occlusion are two …

article 2007
Compromised fertility in a patient with chronic pelvic pain.
The Journal of family practice
article 2007
Does endometrial αvβ3 vitronectin (β3) expression in endometriosis (ENDO) patients predict enhanced outcomes after prolonged GnRH agonist (GnRHa) therapy prior to in vitro fertilization (IVF)?
·doi:10.1016/j.fertnstert.2007.07.440
article 2007
Endometriosis and chronic pain: a multispecialty roundtable discussion.
The Journal of family practice

Pelvic endometriosis is associated with significant morbidity and decreased quality of life. The diagnosis of this condition is challenging: Symptoms vary considerably often mimicking those of other medical conditions. Laparoscopic visualiz…

other 2007
The incidence of aberrant endometrial alphavbeta(3) vitronectin expression in a high risk infertility population: could prolonged GnRH agonist therapy play a role?
Journal of assisted reproduction and genetics ·doi:10.1007/s10815-007-9164-3

PURPOSE: Evaluate the incidence of aberrant endometrial integrin (alphavbeta(3) vitronectin) expression in patients at high risk for implantation defects. MATERIALS AND METHODS: Retrospective case-control trial of 74 consecutive infertile …

review 2006
The role of progestins in treating the pain of endometriosis
Journal of Minimally Invasive Gynecology ·doi:10.1016/j.jmig.2006.06.008
book-chapter 2004
Assisted Reproduction and Endometriosis
·doi:10.3109/9780203319390-23

The mechanisms by which endometriosis may compromise fertility and the roles of surgical and medical therapy are discussed in detail in earlier chapters. Appropriate surgical technique should overcome the mechanical distortion induced by en…

review 2003
Does Surgical Management of Endometriosis Within 6 Months of an In Vitro Fertilization–Embryo Transfer Cycle Improve Outcome?
Journal of assisted reproduction and genetics ·doi:10.1023/a:1025429027610
review 2003
Management of endometriosis-associated infertility
Obstetrics and gynecology clinics of North America ·doi:10.1016/s0889-8545(02)00061-x
book-chapter 2003
Medical Therapy for Endometriosis
·doi:10.1201/b14235-11
article 2003
Tratamiento de la infecundidad relacionada con endometriosis
article 2002
Assisted Reproduction Does Surgical Management of Endometriosis Within 6 Months of an In Vitro Fertilization–Embryo Transfer Cycle Improve Outcome?1

Purpose: To assess the effect on cycle outcome of surgery for endometriosis performed in the 6 months prior to in vitro fertilization–embryo transfer (IVF-ET). Methods: Retrospective analysis of all patients with a primary diagnosis of endo…

article 2002
Effect of prolonged gonadotropin-releasing hormone agonist therapy on the outcome of in vitro fertilization-embryo transfer in patients with endometriosis
Fertility and Sterility ·doi:10.1016/s0015-0282(02)03373-3
book-chapter 2002
Falloposcopy in an office setting
·doi:10.1007/978-2-8178-0841-3_31
article 2002
Prolonged GnRH Agonist and Add-Back Therapy for Symptomatic Endometriosis
·doi:10.1097/00006250-200205000-00008

In Brief OBJECTIVE To assess post-treatment effects in endometriosis patients of a 12-month course of GnRH agonist alone or with one of three “add-back” regimens. METHODS This is a post-treatment follow-up analysis of a randomized, double-m…

article 2002
Prolonged GnRH agonist and add-back therapy for symptomatic endometriosis: long-term follow-up*1
Obstetrics and gynecology ·doi:10.1016/s0029-7844(02)01945-2

OBJECTIVE: To assess post-treatment effects in endometriosis patients of a 12-month course of GnRH agonist alone or with one of three "add-back" regimens. METHODS: This is a post-treatment follow-up analysis of a randomized, double-masked, …

article 2001
Does surgical management of endometriosis (ENDO) within 6 months of in vitro fertilization-embryo transfer (IVF-ET) improve cycle outcome?
·doi:10.1016/s0015-0282(01)02312-3
article 2001
The effect of prolonged GnRH agonist (GnRHa) therapy on in vitro fertilization-embryo transfer (IVF-ET) cycle outcome in endometriosis (ENDO) patients: a multicenter randomized trial.
·doi:10.1016/s0015-0282(01)02442-6
review 2000
Endoscopy in the Evaluation of the Woman Experiencing Infertility
·doi:10.1097/00003081-200012000-00018

Colorado Center for Reproductive Medicine, Englewood, Colorado Correspondence: Eric S. Surrey, MD, Colorado Center for Reproductive Medicine, 799 East Hampden Avenue, Suite #300, Englewood, CO 80110.

review 1999
Add-back therapy and gonadotropin-releasing hormone agonists in the treatment of patients with endometriosis: can a consensus be reached?
Fertility and Sterility ·doi:10.1016/s0015-0282(98)00500-7
review 1998
Add-Back Therapy: Extending Safety and Efficacy of GnRH Analogues in the Gynecologic Patient
Gynecologic and obstetric investigation ·doi:10.1159/000052849

GnRH analogues have been demonstrated to be effective medical therapy for symptomatic endometriosis. The use of these agents has been limited to 6 months due to hypoestrogenic side effects. A variety of steroidal and nonsteroidal add-back r…

article 1998
Historical prospective cohort study of the recurrence of pain after discontinuation of treatment with danazol or a gonadotropin- releasing hormone agonist
Fertility and Sterility ·doi:10.1016/s0015-0282(98)00166-6